OVERVIEW

Clinical and Cost Considerations for Value-Based Multiple Sclerosis Care is organized by Healthcare Made Practical (HMP) Communications LLC and will be held from Jan 15, 2019 - Jan 15, 2020. This CME Conference has been approved for a maximum of 1.0 AMA PRA Category 1 Credits.

Target Audience:
This Activity Is Designed for Pharmacy Directors, Medical Directors, and Other Decision Makers Working in Managed Care Organizations.

Learning Objectives:
After Completing This Activity, Participants Should Be Able to:
• Recognize the Downstream Clinical and Economic Consequences of Delayed or Suboptimal Ms Treatment
• Distinguish Among Available and Emerging Dmts for Ms in Terms of Their Mechanisms of Action, Efficacy, Safety, and Administration
• Outline Key Considerations for Starting, Changing, and Stopping Dmt in Patients With Ms
• Integrate the Risks, Benefits, and Current Recommended Therapeutic Placement of Ms Therapies Into Informed Health Plan Decisions That Facilitate Optimal Treatment Access and Adherence.

Additional details will be posted as soon as they are available.